Position in ALKS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$74,460
+$34,009 QoQ
Shares Held
1,421
+24.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#328
of 423 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Salomon & Ludwin, LLC holds $447,540 across 23 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
1,421 | $74,460 | |
| 2 | LQDA |
Liquidia Corp
|
634 | $50,548 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,028 | $42,178 | |
| 4 | GALDY |
Galderma Group AG/ADR
|
789 | $35,875 | |
| 5 | ZTS |
Zoetis Inc.
|
472 | $33,917 | |
| 6 | HLN |
Haleon plc
|
3,264 | $30,453 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
853 | $28,899 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
498 | $23,161 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,460 | 1,421 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $40,451 | 1,144 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $34,807 | 1,244 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $17,310 | 577 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||